TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/31/24 19:00 | 5/29/24 | ALNY | Alnylam Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Schulman Amy W | MA | D | M.d | 2,005 | 66.83 | 0 | 30 | 8 | D | |||||||||||||||||
5/31/24 19:00 | 5/29/24 | ALNY | Alnylam Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Schulman Amy W | MA | D | S.d | -3,225 | 148.60 | 0 | -22 | -72 | 8 | D | ||||||||||||||||
2/27/23 16:13 | 2/23/23 | ALNY | Alnylam Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Schulman Amy W | MA | D | M.d | 0 | 0.00 | 0 | 0 | New | 0 | D | ||||||||||||||||
12/23/21 17:15 | 12/22/21 | SQZ | Sqz Biotechnologies Co | DE | Health | BioPrd | Biological Products, (No Diag | Schulman Amy W | MA | DT | M.d | 85 | 3.52 | 0 | 24 | 1 | 3,222 | D | |||||||||||||||
12/15/21 17:15 | 12/13/21 | SQZ | Sqz Biotechnologies Co | DE | Health | BioPrd | Biological Products, (No Diag | Schulman Amy W | MA | DT | P | 40 | 10.91 | 0 | 4 | 0 | 3,196 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |